A carregar...
Tumor-derived vaccines containing CD200 inhibit immune activation: implications for immunotherapy
There are over 400 ongoing clinical trials using tumor-derived vaccines. This approach is especially attractive for many types of brain tumors, including glioblastoma, yet so far the clinical response is highly variable. One contributor to poor response is CD200, which acts as a checkpoint blockade,...
Na minha lista:
| Publicado no: | Immunotherapy |
|---|---|
| Main Authors: | , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Future Medicine Ltd
2016
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5619161/ https://ncbi.nlm.nih.gov/pubmed/27485078 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2217/imt-2016-0033 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|